Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Merck Serono (Switzerland) | Researchclopedia

Back to institutions

Merck Serono (Switzerland)

Genevacompany

1,420

Works

200,670

Citations

216

h-index

Top Research Topics

Multiple Sclerosis Research Studies Monoclonal and Polyclonal Antibodies Research Viral Infectious Diseases and Gene Expression in Insects

Top Researchers

Grant W. Montgomery The University of Queensland

1,222 works156,183 citationsh-index: 188

Recent Research

Managing Relapsing Multiple Sclerosis Across the Lifespan: A Narrative Review with Expert Opinion from Norway

Cecilia Smith Simonsen,Marton König,et al.

20260 citations

Protein purification and stability

Ovarian function and disorders

Chronic Lymphocytic Leukemia Research

Reproductive Biology and Fertility

Systemic Lupus Erythematosus Research

Chemokine receptors and signaling

Immunotherapy and Immune Responses

Lung Cancer Treatments and Mutations

Peripheral Neuropathies and Disorders

Anthony E. Lang University of Toronto

1,543 works140,487 citationsh-index: 166

Lewis R. Roberts Mayo Clinic

1,069 works115,262 citationsh-index: 128

Werner Poewe Innsbruck Medical University

1,038 works114,432 citationsh-index: 151

T. Alexopoulos National Technical University of Athens

1,718 works113,915 citationsh-index: 145

Paolo A. Ascierto Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

1,653 works108,712 citationsh-index: 126

The comparative efficacy of cladribine tablets versus alternative disease-modifying treatments for relapsing-remitting multiple sclerosis: Updated meta-regression estimates by patient subgroup

Gerard Harty,Michelle Jones,et al.

20260 citations

International Expert Opinion on Optimal Switching to Cladribine Tablets from Other High-Efficacy Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis: Opportunities and Challenges

Andrew Chan,Raed Alroughani,et al.

20260 citations

Comparative assessment of treatment switching in patients with multiple sclerosis receiving cladribine tablets versus fingolimod, dimethyl fumarate, and teriflunomide

Carroline Lobo,Gabriel Gomez Rey,et al.

20260 citations

S1:04 Enpatoran, a toll-like receptor 7/8 inhibitor, in skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: pooled safety data from the phase 2 willow trial

Eric F Morand,Victoria P Werth,et al.

20260 citations

PO:11:286 Design of a phase 3, randomised, double-blind, placebo-controlled parallel study to evaluate the efficacy and safety of enpatoran in cutaneous manifestations of lupus with or without systemic disease

Eric F Morand,J Michelle Kahlenberg,et al.

20260 citations